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ABSTRACT
The integrated activity of cis-regulatory elements
fine-tunes transcriptional programs of mammalian
cells by recruiting cell type–specific as well as ubiq-
uitous transcription factors (TFs). Despite their key
role in modulating transcription, enhancers are still
poorly characterized at the molecular level, and their
limited DNA sequence conservation in evolution and
variable distance from target genes make their unbi-
ased identification challenging. The coexistence of
high mono-methylation and low tri-methylation lev-
els of lysine 4 of histone H3 is considered a signa-
ture of enhancers, but a comprehensive view of hi-
stone modifications associated to enhancers is still
lacking. By combining chromatin immunoprecipita-
tion (ChIP) with mass spectrometry, we investigated
cis-regulatory regions in macrophages to compre-
hensively identify histone marks specifically asso-
ciated with enhancers, and to profile their dynam-
ics after transcriptional activation elicited by an in-
flammatory stimulation. The intersection of the pro-
teomics data with ChIP-seq and RNA-seq analyses
revealed the existence of novel subpopulations of
enhancers, marked by specific histone modification
signatures: specifically, H3K4me1/K36me2 marks
transcribed enhancers, while H3K4me1/K36me3
and H3K4me1/K79me2 combinations mark distinct
classes of intronic enhancers. Thus, our MS analysis
of functionally distinct genomic regions revealed the
combinatorial code of histone modifications, high-
lighting the potential of proteomics in addressing
fundamental questions in epigenetics.
INTRODUCTION
In eukaryotes, gene transcription is tightly controlled in
time and space by cis-regulatory regions. These include both
proximal regions, such as promoters located directly up-
stream of the transcription start sites (TSS), and distal regu-
latory elements, such as enhancers, silencers, insulators and
locus control regions (LCR), which are platforms for re-
cruiting transcription activators and suppressors that act
synergistically to enforce specific transcriptional programs
during development, differentiation and response to envi-
ronmental stimuli.
In particular, enhancers play a crucial role in setting
cell- and time-specific gene expression programs. They
are capable of promoting transcription of their target
genes at a considerable distance (up to several hundred
kb), in an orientation-independent manner (1–6). En-
hancers are characterized by DNA hypersensitivity to
nucleases, nucleosome-depleted regions and clustering of
DNA binding-motifs for TFs (7–12). Usually, enhancer ac-
tivation requires the collaborative interaction of multiple
TFs, including ubiquitous, pioneer or lineage-determining
(LD) and signal-dependent (SD) TFs (13–17). Lineage-
determining TFs can bind specific DNA motifs in com-
pacted chromatin, creating a nucleosome-free region that
can be bound by other TFs and co-activators (such as hi-
stone modifiers, ATP-dependent chromatin remodelers or
bridging factors for long-range cross-talks with the basal
transcriptional machinery at promoters) that ultimately
control transcription (18,19).
Genome-wide studies indicate that enhancers exhibit
a characteristic histone post-translational modification
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(PTM) ‘signature’, consisting of high levels of mono-
methylation, with low levels of tri-methylation, at lysine 4
on histone H3 (H3K4me1Hi/K4me3Low) (20–22). Never-
theless, only a fraction of genomic regions with this signa-
ture are inherently active enhancers, which are also marked
by H3K27 acetylation and actively transcribing RNA poly-
merase II (23,24).
Recent evidence suggests that chromatin modifications
provide an important layer of enhancer regulation, by ei-
ther serving as docking sites for signal-dependent TFs or
promoting the access to other TFs; this would support
the assembly of transcriptional complexes and long-range
chromatin interactions, which altogether enforce specific
transcriptional responses (14,25). For instance, H2Bmono-
ubiquitination stabilizes the histone variant H2A.Z at in-
ducible enhancers regulated by the estrogen receptor alpha,
which blocks binding of the chromatin remodeler INO80
and, consequently, the transcriptional activation of these
enhancers (26).
Genome-wide characterization of chromatin features as-
sociated with cis-regulatory elements has been facilitated
by ChIP-seq analysis. However, a comprehensive and un-
biased picture of histone modification patterns associated
with these regions is still lacking (27,28). This information
would be invaluable to first identify genomic enhancers and
then classify them into distinct subpopulations that regulate
specific transcriptional programs, as well as to decipher the
molecular mechanisms underlying their function.
Taking advantage of a native chromatin proteomics
(N-ChroP) approach (29), we combined mass spectrom-
etry (MS) and native ChIP (N-ChIP) against H3K4me1
and H3K4me3 to determine which histone PTMs are dif-
ferentially associated with enhancers and promoters in
macrophages.Macrophages provide an ideal system, as they
have been well-studied at the genomic and epigenomic lev-
els and are highly responsive to inflammatory stimuli, with a
rapid and dynamic activation of hundreds of inflammatory
genes involved in the innate and adaptive immune response.
MS has been previously used to identify and quantify his-
tone PTMs in an unbiased and comprehensive manner (30–
35), and to characterize long-distance synergies between
different PTMs when combined with histone digestion pro-
tocols that produce long polypeptides (36–40). However,
MS analysis for epigenetic profiling has been so far largely
limited to bulk chromatin, with only a few MS-based stud-
ies attempting to dissect histone PTMs in specific chromatin
regions (41,42).
Using N-ChroP on resting or lipopolysaccharide (LPS)-
stimulated macrophages over a time course, we profiled
42 distinct modified peptides from histones H3 and H4
and identified known and novel marks specifically en-
riched at enhancers. The unexpected enrichment on his-
tone H3 of lysine 36 di- and tri-methylation (H3K36me2
andH3K36me3) and lysine 79 di-methylation (H3K79me2)
in H3K4me1-rich regions suggested the existence of sub-
categories of enhancers marked by these PTMs. Indeed,
by analyzing ChIP-seq data using an unsupervised learn-
ing strategy, we identified significant genome-wide co-
associations between these marks. Intersecting ChIP-seq
data with total and nascent transcript analyses, we also
found that H3K4me1/K36me3 and H3K4me1/K79me2
signatures mark intronic enhancers involved in distinct
inflammatory gene expression programs, while the dual
H3K4me1/K36me2 mark mainly accumulates at tran-
scribed enhancer regions.
By applying N-ChroP to dissect enhancers, we have pro-
vided further support to the histone code hypothesis, show-
ing that distinct combinations of marks define functionally
different regions of the genome. The novel epigenetic signa-
tures that have emerged in this study will be valuable both
for de novo identification of enhancer subpopulations and
for dissecting the molecular mechanisms behind the activa-
tion of distinct enhancers in response to stimuli.
MATERIALS AND METHODS
Cell culture
RAW 264.7 macrophage-like cells were cultured in high-
glucose Dulbecco’s modified Eagle’s medium (DMEM, In-
vitrogen) containing 10% low endotoxin FCS, 1% glu-
tamine and 1% Pen/Strep. Cells were stimulated with
lipopolysaccharide (LPS) from Escherichia coli serotype
EH100 (Alexis) at 100 ng/ml for 1 or 4 h. Transcription
was inhibited with 1Mflavopiridol (Sigma, St. LouisMO,
USA) 1 h prior to LPS stimulus, as previously described
(43).
Native chromatin immunoprecipitation (N-ChIP)
Approximately 20–30 × 106 of RAW cells were homoge-
nized in lysis buffer (10% sucrose, 0.5 mM EGTA [pH 8.0],
15 mM NaCl, 60 mM KCl, 15 mM HEPES, 0.5% Triton,
0.5 mM PMSF, 1 mM DTT, 5 mM NaF, 5 mM Na3VO4,
5 mM sodium butyrate, 5 g/ml aprotinin, 5, g/ml pep-
statin A and 5 g/ml leupeptin), and nuclei were separated
from cytoplasm by centrifugation at 3750 rpm (4◦C) for 30
min on sucrose cushions. Nuclear pellets were washed twice
with phosphate buffered saline (PBS), re-suspended in di-
gestion buffer (0.32 M sucrose, 50 mM Tris–HCl [pH 7.6],
4 mM MgCl2, 1 mM CaCl2 and 0.1 mM PMSF) and di-
gested with micrococcal nuclease (MNase, Roche) at a fi-
nal concentration of 0.01 U/l, for 60 min at 37◦C. The
reaction was stopped by adding 1 mM EDTA and chill-
ing on ice. After centrifugation of re-suspended nuclei at
10 000 rpm (4◦C) for 10 min, the soluble fraction of chro-
matin (S1) comprising smaller fragments (mono- and di-
nucleosomes), was collected as the supernatant. Pellets were
re-suspended in dialysis buffer (10 mM Tris–HCl [pH 7.6],
1 mM EDTA, 0.5 mM PMSF, 5 mMNaF, 5 mMNa3VO4,
5 mM sodium butyrate and 1× protease inhibitor cocktail)
and dialyzed overnight at 4◦C in a dialysis tube (cut off 3.5
kDa). The second soluble fraction of chromatin (S2), com-
prising large fragments (tri- to hepta-nucleosomes), was
likewise obtained after centrifugation at 10 000 rpm (4◦C)
for 10 min. DNA was extracted using QIAquick columns
(QIAGEN) and then run on 1% agarose gel to evaluate the
chromatin fractions. The S1 fraction was combined with a
small aliquot of the S2 fraction and diluted in ChIP dilution
buffer (50 mM Tris–HCl [pH 7.6], 50 mMNaCl and 5 mM
EDTA). Chromatin was incubated overnight at 4◦C with
H3K4me1 (ab8895, 25 g), H3K4me3 (active motif 39159,
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30 l) or H3K9me3 (ab8898, 25 g) antibodies. In paral-
lel, 200–250 l of G protein–coupled magnetic beads (Dyn-
abeads, Invitrogen 100.04D) was blocked in 0.5% BSA in
PBS overnight at 4◦C. Blocked beads were washed, added to
chromatin and incubated for 3 h at 4◦C on a rotating wheel.
Beads were washed four times (with 50 mM Tris–HCl [pH
7.6] and 10 mMEDTA) using increasing salt concentration
for the last three washes (of 75, 125 and 175 mM NaCl).
LDS sample buffer (InvitrogenNP0007) supplementedwith
50 mM DTT was added to the beads for 5 min at 70◦C
to elute the immunoprecipitated proteins from the beads.
Proteins were resolved on 4–12% Bis-Tris acrylamide SDS-
PAGE pre-cast gels (Invitrogen NP0335BOX) on an Invit-
rogen system and visualized using Colloidal Blue Staining
kit (Invitrogen LC6025) to ensure the immunopurification
of intact nucleosomes containing all histones at the same
stochiometry. To analyze the basal histone PTMs, three bi-
ological replicates (n = 3) for each ChIP, using H3K9me3
as a ‘negative’ control for cis-regulatory regions enrichment,
were performed while for the dynamic experiment we per-
formed three biological replicates (n= 3) for each time point
(1 and 4 h after LPS treatment).
In-gel digestion of core histones
Bands corresponding to histones H3 and H4 were excised
and in-gel digested, as previously described (29). Briefly, gel
bands were cut in pieces and de-stained with H2O 100% al-
ternatedwith dehydration steps in 50%acetonitrile (inH2O)
and 100% acetonitrile. Gel pieces were then chemically alky-
lated in-gel by incubation with D6-acetic anhydride (Sigma
175641) 1:9 in 1M NH4HCO3 (60–70 l final volume) and
saturated CH3COONa solution as a catalyzer. After 3 h at
37◦C with vigorous shaking in a thermomixer, chemically-
modified gel slices were washed with NH4HCO3 and alter-
nating with ACN at increasing % (from 50 to 100). In-gel
digestion was performed with 100 ng/l trypsin (Promega
V5113) in 50 mM NH4HCO3 at 37◦C overnight, in order
to obtain an ‘in-gel’ ArgC-like digestion, which cleaves at
the amide bond C-terminal to arginine residues, produc-
ing peptides with an optimal length for MS analysis. Fi-
nally, digested peptides were collected and extracted using
5% formic acid alternated with ACN 100%.
Digested peptides were desalted and concentrated using
a combination of reverse-phase C18/carbon ‘sandwich’ sys-
tem and ion-exchange (SCX) chromatography, on hand-
made nano-columns (StageTips) (44); digested peptides
loaded on C18/carbon and SCX StageTips were then eluted
with high-organic solvent (80% ACN/0.5% acetic acid)
and 5% NH4OH/30% methanol, respectively. Eluted pep-
tides were lyophilized, re-suspended in 1% TFA in ddH2O,
pooled and subjected to LC–MS/MS.
Nanoflow liquid chromatography and tandem-mass spec-
trometry (nLC-MS/MS)
Peptide mixtures were analyzed by online nanoflow liquid
chromatography tandem-mass spectrometry (LC–MS/MS)
using an EASY-nLC™ 1000 (Thermo Fisher Scientific,
Odense, Denmark) connected to a Q-Exactive instrument
(Thermo Fisher Scientific) through a nanoelectrospray ion
source. The nano LC system was operated in one column
set-up with a 25-cm analytical column (75 m inner diam-
eter, 350 m outer diameter) packed with C18 resin (Re-
proSil, Pur C18AQ 1.9 m, Dr Maisch, Germany) config-
uration. Solvent A was 0.1% FA in ddH2O, and solvent B
was 80% ACN with 0.1% FA. Samples were injected in an
aqueous 1% TFA solution at a flow rate of 500 nl/min. Pep-
tides were separated with a gradient of 0–40% solvent B
over 100 min followed by a gradient of 40–60% in 5 min
and 60–95% over 5 min at a flow rate of 250 nl/min in
the EASY-nLC 1000 system. The Q-Exactive instrument
was operated in the data-dependent mode (DDA) to auto-
matically switch between full-scan MS and MS/MS acqui-
sition. Survey full scan MS spectra (from m/z 300–1350)
were analyzed in the Orbitrap detector with resolution R =
60 000 at m/z 200. The ten most intense peptide ions with
charge states ≥2 were sequentially isolated to a target value
of 3e6 and fragmented by higher energy collision dissoci-
ation (HCD) with a normalized collision energy setting of
28%. The maximum allowed ion accumulation times were
20 ms for full scans and 100 ms for MS/MS, and the target
value for MS/MS was set to 1e5 (R = 15 000 at m/z 200).
The dynamic exclusion time was set to 20 s for Q-Exactive
instrument. Standard mass spectrometric conditions for all
experiments were: spray voltage, 2.4 kV; no sheath and aux-
iliary gas flow.
Analysis of mass spectrometric data and histone PTM profil-
ing
Acquired raw data were analyzed by the integrated
MaxQuant software v.1.5.2.8, using the Andromeda search
engine (45,46). TheMOUSE 1401 database (51 195 entries)
was used for peptide identification. Enzyme specificity was
set to Arg-C, because the chemical derivatization of lysines
with deuterated acetic anhydride prior to trypsin digestion
results in an Arg-C–like digestion. In MaxQuant, the esti-
mated false discovery rate (FDR) of all peptide identifica-
tions was set to a maximum of 1%. The main search was
performed with a mass tolerance of 6 ppm. A maximum of
2missed cleavages was permitted, and theminimumpeptide
length was set at six amino acids.
The peptide search focused on lysine methylation and
acetylation, with the variable modifications of lysine
D3-acetylation (+45.0294 Da), lysine mono-methylation
(masses of D3-acetylation [+45.0294] plus mass of mono-
methylation [+14.016 Da]), lysine di-methylation (+28.031
Da), lysine tri-methylation (42.046 Da) and lysine acety-
lation (+42.010 Da) were included. To reduce the rate of
false positives, which increases with increasing the num-
ber of variable modifications included in the database
search (47), raw data were analyzed with multiple and
parallel MaxQuant jobs, setting different combinations
of variable modifications: (i) D3-acetylation, lysine mono-
methylation, lysine di-methylation and lysine acetylation;
(ii) D3-acetylayion with lysine mono-methylation and ly-
sine tri-methylation and (iii) D3-acetylayion with tri-
methylation and lysine acetylation. MaxQuant search re-
sults were exported, and peptides scoring lower than 60
(corresponding to a Mascot score of 15 (46)) and with
a localization probability score <0.75 (following previous
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phospho-PTM studies (48,49)) were removed, as they were
identified with low confidence (peptides parameters and
output from MQ analysis are given in Supplementary Ta-
bles S1 and S2). Filtered data were subjected to manual
inspection and validation using QualBrowser version 2.0.7
(ThermoFisher Scientific). Extracted ion chromatograms
(XIC) were constructed for each precursor based on the
m/z value, using a mass tolerance of 10 ppm and a mass
precision of up to four decimals. For each histone-modified
peptide isoform, its relative abundance percentage (RA%)
was estimated by dividing the area under the curve (AUC)
of each modified peptide by the sum of all the AUC values
of all observed isoforms of that peptide. Hence, the RA %
value for each specific peptide represents the relative pro-
portion of that peptide among all quantified peptide forms
sharing the same amino acid sequence (50,51). The relative
enrichment of each PTM, both at the basal state and after
LPS stimulus, was calculated as a ratio between its RA %
in the ChIP and in the input. Visualization of histone PTM
enrichment and unsupervised hierarchical clustering were
performed with Perseus, setting correlation distances and
complete linkage as parameters (52). Differences among hi-
stone PTMs associated to a specific chromatin region were
assessed by t-test analysis, followed by Bonferroni’s post-
hoc test. Visualisation of MS/MS spectra for each modifi-
cationwas performed using theViewer tool (Supplementary
Figure S9) in MaxQuant.
ChIP-seq and RNA-seq analyses
For ChIP-seq, ∼10 × 106 of untreated or stimulated (1
or 4 h after LPS) RAW cells were used for each experi-
ment. Cells were crosslinked with 0.75% formaldehyde for
10 min at room temperature, and chromatin was soni-
cated as described previously (29). Each chromatin input
was immunoprecipitated with 10 g of the following anti-
bodies: H3K4me1 (Abcam 8895), H3K4me3 (Active Mo-
tif 39159), H3K36me2 (Abcam 9049), H3K79me2 (Ab-
cam ab3594), H3K36me3 (Abcam 9050), H3K27ac (Ab-
cam 4729), H3K27me3 (Cell Signalling 9733) and Pu.1
(Santa Cruz sc-352). After immunoprecipitation, beads
were washed three times in buffer A (20 mM Tris–HCl [pH
7.6], 2 mM EDTA, 0.1% SDS, 1% Triton-100 and 150 mM
NaCl), once in buffer B (20 mM Tris–HCl [pH 7.6], 2 mM
EDTA, 0.1% SDS, 1% Triton-100 and 300 mM NaCl) and
once in TE containing 50mMNaCl. DNAwas eluted in TE
containing 2% SDS and de-crosslinked overnight at 65◦C.
DNA was purified by QIAquick columns (QIAGEN) and
quantified with Picogreen. Sequencing libraries were gener-
ated as previously described (53,54) and sequenced on an Il-
lumina HiSeq2000. Total RNA was extracted from 2 × 106
cells usingRNeasyKit (QIAGEN)withDNase I treatment.
Libraries were then prepared using TruSeq RNA sample
preparation Kit (Illumina) after depleting ribosomal RNA
and sequenced on an Illumina HiSeq2000.
Computational methods
ChIP-seq analysis. Reads derived from internal ChIP-seq
experiments andH3K9me3 ChIP-seq reads taken from (54)
were aligned to the mouse genome (assembly mm9) using
BowTie (55), allowing up to three mismatches and keeping
only reads mapping uniquely (for histone PTMs) or at most
at 10 different positions of the genome (for Pu.1). MACS2
was used to identify regions of reads enrichment compared
to a control DNA input, either by using default parameters
(Pu.1) or by allowing the identification of broad regions of
enrichment in the analysis of histone PTMs (56).
To analyze composite combinatorial interactions of
the different histone PTMs––in both basal and inflamed
states––we employed the automated computational sys-
tem for learning chromatin states ChromHMM (57).
ChromHMM segments the genome into regions of 200 bp,
such that it was possible to evaluate the presence/absence
for each histone PTM according to the reads enrichment
against a control. The resulting datawas used to train amul-
tivariate hiddenMarkovmodel for unsupervised learning of
chromatin states, where each state corresponded to a com-
bination of presence/absence of each modification; training
used default parameters, and models up to 35 states were
evaluated. In each analysis, the model with the maximum
number of non-redundant states was chosen. When analyz-
ing chromatin states across different conditions (untreated
or induced with LPS for 1 or 4 h), models were learned us-
ing all histone PTMs under analysis, with a distinct cell-type
label assigned to all modifications belonging to the same
treatment, in order to obtain a chromatin state model ap-
plicable to all conditions. For the subsequent analysis on
localization of specific chromatin states, regions identified
as K4me1-positive (K4me1/K36me2, K4me1/K36me3 or
K4me1/K79me2) that were separated on the genome by
less than 2 kb were merged, and overlapping regions of
H3K4me1-only containing states were removed, in order to
obtain less ambiguous calls for the overlap with genomic
features.
Genomic annotations of peaks or chromatin states were
performed either using HOMER or with the bedIntersect
function of BedTools (14,58).
Read distributions around Pu.1 summits were calcu-
lated using in-house–developed scripts. Statistical analy-
sis and plots were performed using R. Gene ontology
(GO) term enrichment was performed with the latest ver-
sion of the online tool DAVID (59). Every analysis used
standard parameters, with a specific background superset
of genes for every group of analyzed genes; for instance,
for genes harboring K79me2- or H3K36me3-marked en-
hancers, a background of the respective population of all
H3K79me2 or H3K36me3 positive genes was used, while
for the H3K79me2-marked active enhancers gene subpop-
ulation, a background of all genes with an intergenic en-
hancer marked by H3K79me2 was used.
To identify intronic enhancers transitioning from class
II to class I, class II was first defined as only those re-
gions that showed co-localization of both K4me1 and
K27me3 in the untreated condition, based on the 27-state
ChromHMM model. Overlap between these regions, and
emissions marked by both K4me1 and K27ac identified af-
ter LPS treatment (1 and 4 h) were determined, and regions
were mapped onto RefSeq genes. GO enrichment of the re-
sulting lists was computed with DAVID, using the whole
mm9 RefSeq gene annotation as background.
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Enrichment analysis of known TF binding motifs was
carried out using the corresponding function of the
HOMER suite, using the entire length of the input regions
to calculate the enrichments.
RNA-seq analysis. Reads resulting from total RNA-seq
and nascent RNA-seq (taken from (60), GSE66955) were
aligned and quantified over the mouse genome (mm9) Ref-
Seq gene annotation using RSEM (61), with default pa-
rameters and the addition of the strand-specific informa-
tion for the nascent RNA dataset. BedIntersect was used
to map chromatin states on RefSeq genes. Nascent RNA
was aligned mm9 on the using TopHat (62). Intergenic
emissions were considered as transcribed only when the
mapped read yielded a transcription value passing a cut-off
of RPKM >0.5. Genomic localizations of intergenic tran-
scripts were evaluated as in (60); briefly, overlap was first
evaluated for lincRNAs (as annotated by Ensembl (63)),
then for super-enhancers (annotation taken from (64)), and
finally with regions within 2 kb from a TSS or a TTS.
Remaining regions were annotated as ‘active’ or ‘poised’
based on their K27ac status. All statistical analyses were
performed using the corresponding R functions and pack-
ages.
RESULTS
Characterization of histone PTMs associated with cis-
regulatory regions in macrophages
ChIP followed by MS-based proteomics (ChroP) enables
in-depth characterization of the proteomic composition
of spatially and functionally defined chromatin regions
(29). Here, this approach was further implemented to
carry out a comprehensive and unbiased mapping of his-
tone PTMs specifically co-enriched at proximal and distal
cis-regulatory regions of mouse macrophage-derived cells
RAW 264.7. These regions were enriched prior to MS us-
ing as baits H3K4me1 and H3K4me3 as markers of en-
hancers and promoters, respectively, as well as H3K9me3
as a marker of inactive chromatin regions (as a nega-
tive control). Antibody specificity for specific methylation-
states and residues within histones was confirmed by using
MODifiedTM histone peptide arrays and dot blot analysis
(Supplementary Figure S1A, B and Table S3).
Nuclei from asynchronously growing cells were enzymat-
ically digested withmicrococcal nuclease (MNase) and used
as input for chromatin immunoprecipitations, with each in-
dividual N-ChroP experiment performed in three biolog-
ical replicates. After immunoprecipitation, proteins were
separated by SDS-PAGE and bands corresponding to hi-
stones H3 and H4 were excised and digested (65). Peptides
were analyzed through ultra-high-performance liquid chro-
matography coupled to high-resolution MS/MS analysis
(UHPLC-MS/MS), to enhance the separation and detec-
tion of hyper-modified histone peptides (66). Enrichment
of each histone modification, and combinations thereof, in
the distinct chromatin fractions was evaluated as the ratio
of its percentage of relative abundance (RA%) between the
ChIP and the input (Figure 1A).
A significant proportion of the H3K4me1-nucleosomes
were captured by ChIP (Supplementary Figure S1C).
A similar efficiency was achieved with H3K4me3 and
H3K9me3 ChIPs, as previously shown (29). H3K4me1 was
chosen for enhancer enrichment on the basis of the well-
known H3K4me1Hi/ H3K4me3Low signature commonly
associated with enhancers. However, H3K4me1 enrichment
is often found associated with other genomic regions (e.g.
regions flanking TSS of transcribed genes). Thus, to as-
sess the selectivity of our bait, we compared the ChIP-seq
profiles of H3K4me1 and Pu.1, a pioneer TF highly ex-
pressed in macrophages that binds to macrophage-specific
enhancers and is essential for establishing and maintain-
ing macrophage identity and viability (67). Pu.1 is also
essential for stably maintaining H3K4me1 at these regu-
latory regions and is a well-known marker of enhancers
in macrophages, with a much lower occurrence at TSS
(14,54,68,69). H3K4me1-positive regions significantly over-
lapped with Pu.1 binding sites (∼70%; Supplementary Fig-
ure S1D). Moreover, only 5% of the fraction of TSS over-
lapping withH3K4me1-positive regions was excluded when
Pu.1 was used as a further discriminant (Supplementary
Figure S1E), indicating that the specificity of H3K4me1 for
enhancers was comparable to that of Pu.1, with only minor
cross-contamination from TSS.
We next profiled the enrichment/depletion of 42 differen-
tially modified histone peptides fromH3K4me1, H3K4me3
and H3K9me3 N-ChroP experiments. Unsupervised hier-
archical clustering segregated three distinct groups that
matched the three baits, with biological replicates of each
individual experiment clustering together, underscoring the
high experimental and biological reproducibility of the
assay (Figure 1B). Notably, an enrichment of H3K4me1
at putative enhancers was complemented by an overall
H3K4me3 slight depletion in the same regions, confirming
the existence of the H3K4me1Hi/K4me3Low signature (Fig-
ure 1B, Supplementary Figure S2A–C) (20). The H3K4me3
ChIP, in contrast, was characterized by a strong enrichment
of H3K4me3, as well as of H3K4me1 (albeit to a much
lower extent), indicating promoter enrichment (Figure 1B,
Supplementary Figure S2A–C). In the H3K9me3 ChIP, the
bait was specifically enriched, both alone and in combina-
tion with acetylated H3K14, as expected (Figure 1B, Sup-
plementary Figure S2A and B). The observed MS-based
enrichment of distinct chromatin regions pertaining to pro-
moters and enhancers was further supported by results from
western blots (SupplementaryFigure S2D) and quantitative
PCR analyses (Supplementary Figure S2E).
The significant depletion of H3K9me2 and H3K9me3 in
both H3K4me1 and H3K4me3 ChroP experiments (Fig-
ure 1C) is in line with their known accumulation at in-
active chromatin regions. Strikingly, both enhancers and
promoters were enriched in hyper-acetylated H3 and H4
peptides; more specifically the tetra-acetylated N-terminal
tail of H4 was significantly enriched at both regions, while
acetylated H3K18, H3K23 and H3K14 (alone or together
with H3K9 acetylation) were more enriched at promoters
(t-test P≤ 0.05) (Figure 1C). These data are consistent with
the well-described functional link between histone acetyla-
tion and transcriptionally active chromatin, suggesting dif-
ferent specificity of the corresponding HATs at the two reg-
ulatory regions.
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Figure 1. Distinct chromatin regions isolated by the N-ChroP strategy. (A) Scheme of the N-ChroP experimental approach. (B) Heatmap visualisation
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Interestingly, H3K79me1 and H3K79me2 were signif-
icantly enriched both at enhancers and promoters (Fig-
ure 1C), in line with available evidence indicating that
these marks accumulate at actively transcribed genes (70).
Moreover, N-ChroP revealed a specific co-association of
H3K4me1 with H3K36me2/K36me3 marks (Figure 1C),
which are usually associated with transcription elonga-
tion due to their accumulation at the 3′ of active genes
(71,72). Amore in-depth evaluation of theMSdata revealed
that all H3 peptides containing di- and tri-methylated
K36, including K27me1/K36me2, K27me2/K36me2 and
K27me1/K36me3, were significantly enriched at H3K4me1
enhancers (Figure 1C). As independent experiments in
which ChIP was followed by western blot confirmed these
MS results, we conclude that H3K36me2 is specifically en-
riched at enhancers and that H3K79me2 is found at both
enhancers and TSS (Figure 1D).
Unexpectedly, we found that acetylation of H3K27
(K27ac), a known marker of active enhancers (23), was not
enriched in chromatin domains containing H3K4me1 (Fig-
ure 1B, Supplementary Figure S3A). As N-ChroP selects
the entire pool of H3K4me1 enhancers, this lack of en-
richment could be due to not having a sufficiently abun-
dant fraction of K27ac-labelled ones for reliable MS de-
tection. However, the observation that this modification
is detectable per se by N-ChroP (with a slight enrichment
in H3K4me3-positive regions; Supplementary Figure S3B)
challenges the detection limit hypothesis. Recent results
showing that K27ac associates significantly to TSS may ex-
plain this quite unexpected result (73).
H3K27me1 and H3K18me1 were significantly depleted
at enhancers, and H3K18me1 was also depleted at
TSS (Figure 1B and C). The H3K18me1 enrichment
in silent domains––mirrored by its depletion at active
domains––had been already observed by N-ChroP (29) and
is in line with data supporting its role in silent chromatin,
such as its antagonism to H3K18ac and having a maxi-
mal half-life lower than that of all histone lysine mono-
methylations with active functions (74,75).
Genome-wide mapping of H3K36me2, H3K36me3 and
H3K79me2 corroborates N-ChroP data
The most unexpected observation from systematic his-
tone PTM analysis by N-ChroP was the co-association of
H3K36me2/me3 and K79me2 with H3K4me1, which we
therefore further investigated with genome-wide localiza-
tion analyses. We validated the association of H3K36me2,
H3K36me3 and H3K79me2 with H3K4me1-nucleosomes
by ChIP-seq using antibodies whose specificity was care-
fully assessed (Supplementary Figures S1A, B and S3B,
Supplementary Table S3): genomic distribution of these
marks showed that H3K36me2 (in a total of 50 748 peaks)
frequently associates with intronic and extragenic regions
(64% and 34%, respectively), with a pattern very similar to
H3K4me1. In contrast, H3K36me3 (in a total of 28 167
peaks) and H3K79me2 (in a total of 13 412 peaks) accu-
mulate mainly at introns (83% and 84%, respectively). As
a control, ChIP-seq profiles of the three baits showed the
well-characterized genomic localizations (Figure 2A).
We next used the ChromHMM segmentation approach,
which identifies significant genome-wide co-associations
of histone marks (chromatin states) through unsupervised
clustering of different histone PTM profiles (57). Analysis
of all ChIP-seq profiles in resting macrophages generated
known chromatin states––such as the H3K4me1/K4me3
combination that marks regions flanking active TSS––and
confirmed that H3K4me1/me3 and H3K9me3 do not over-
lap. Moreover, we identified regions in which H3K4me1
was co-enrichedwithH3K36me2/K36me3 andH3K79me2
(Figure 2B), confirming the patterns that emerged from N-
ChroP. In addition, frequency analysis of chromatin states
shows that H3K4me1-rich regions had 26%, 10% and 24%
overlap with H3K36me2-, H3K36me3- and H3K79me2-
positive regions, respectively, further highlighting the sen-
sitivity of N-ChroP in detecting PTM co-associations with
relatively low abundance (Figure 2C).
To assess how these marks distribute within H3K4me1-
enriched chromatin states, we next assessed their cumula-
tive distributions around Pu.1 bound regions (which are
in H3K4me1-enriched chromatin states) (Figure Supple-
mentary S4A). While H3K4me1 is enriched in the nucleo-
somes flanking the nucleosome-depleted regions bound by
Pu.1 (14), H3K36me2/K36me3 and H3K79me2 have a bi-
modal pattern that centers around the nucleosome-free re-
gion, with a maximum enrichment located further down-
stream and upstream of Pu.1 bound regions (Figure 3A, B,
Supplementary S4B). Hence, we concluded that these mod-
ifications can co-occur with H3K4me1 to define a broader
region surrounding Pu.1 peaks.
Dynamic profiling of histone modification changes at cis-
regulatory regions upon inflammatory stimulation
In macrophages, inflammatory stimuli elicit extended tran-
scriptional activation, during which synchronized changes
in gene expression are caused by the combined activity of
cell-specific pioneer and stimulus-dependent chromatin de-
terminants at cis-regulatory regions of inflammatory genes
(16,76,77). The expression profiles of a panel of inflamma-
tory genes at different times after LPS stimulation showed
that most of them were already significantly transcription-
ally activated at 1 h, with peaks at 4 h after LPS (Sup-
plementary Figure S5A, B). To cover the acute phase of
the inflammatory transcriptional response, we used the time
points of 0, 1 and 4 h after LPS treatment for our dynamic
chromatin proteomic experiments in RAW 264.7 cells (Fig-
ure 4A). Consistent with previous ChIP-seq evidence, the
level of H3K4me1 in the immunoprecipitated chromatin re-
mained constant across the three time points (Figure 4B
and C), confirming that it is an ideal bait for profiling co-
associated modifications over time.
The analysis of 42 differentiallymodified histone peptides
at the three time points showed a mild increase of global
histone H3 and H4 acetylation, in line with the model of
hyper-acetylation leading to chromatin relaxation, which
in turn increases the accessibility of stimulus-specific TFs
(Figure 4B and C) (78,79). A more composite picture, how-
ever, emerged after an in-depth dissection of distinct acety-
lation sites: some acetylated histone peptides (e.g. tri- and
tetra-acetylated isoforms of the H4 tail) increased during
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inflammation, whereas others (e.g. H3K18ac/K23ac) re-
mained constant (Figure 4B and C). This result could in-
dicate that the constitutively acetylated state is character-
ized by marks different than the LPS-induced acetylated
state, as a consequence of the activity of distinct HATs.
H3K4me3, a prototypic mark of promoters of actively tran-
scribed genes (20,80), also increased after LPS treatment
(Figure 4B and C, Supplementary Figure S6A). Interest-
ingly, H3K4me2 followed the same trend, suggesting that,
in this context, this mark may have a role more similar to
H3K4me3 than to H3K4me1.
We observed an interesting decrease for the silencing
marksH3K9me3 andH3K27me2/me3, and forH3K36me1
(Figure 4B andC), corroborating previous evidence indicat-
ing a synergy betweenH3K36me1 andH3K27me2 in estab-
lishing gene silencing (81).
The overall levels of H3K36me2/me3 andH3K79me2 re-
mained stable during the early inflammatory response (Fig-
ure 4B and C), displaying a behavior similar to H3K4me1;
this was confirmed bywestern blot analysis (Supplementary
Figure S6A). ChIP-seq profiles ofH3K36me2/K36me3 and
H3K79me2 at the three time points further confirmed that
the overall abundance and genomic localization of these
marks was stable (Figure 4D and E, Supplementary Fig-
ure S6B and C), suggesting that these marks synergize with
H3K4me1 to maintain specific epigenetic signatures within
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and H3K79me2 relative to the H3K4me1 and Pu.1 profiles.
distinct enhancer subpopulations during the acute inflam-
matory response.
The co-association of H3K4me1 with H3K79me2 and
H3K36me3 identifies distinct intronic enhancer subpopula-
tions
H3K79me2 and H3K36me3 are typically enriched at
transcribed genes, with the former mainly localized in
proximity of TSS and the latter accumulating at the 3′
end of gene bodies (71,82). Accordingly, histone PTM
analysis displayed the enrichment only of H3K79me2
in H3K4me3-enriched chromatin, while both were over-
represented in H3K4me1-containing nucleosomes (Figure
1B). Chromatin state analysis identified three chromatin
states: H3K4me1/K79me2, H3K4me1/K4me3/K79me2,
and H3K4me3/K79me2 (chromatin states #5, #6 and #7,
respectively) (Figure 2B). While chromatin states #6 and
#7 accumulated around promoters (but located differen-
tially relative to TSS), the chromatin state #5 was found
mainly within introns (Figure 5A and B). Interestingly, the
chromatin state characterized by H3K4me1/K36me3 (#11;
Figure 2B) was over-represented at introns (Figure 5A and
B), suggesting that multiple subpopulations of intronic en-
hancers exist and are marked by distinct combinations of
H3K4me1 with other PTMs.
To gain insight into the role of H3K79me2 and
H3K36me3 in regulating the respective subpopulations of
intronic enhancers, we repeated the chromatin state anal-
ysis but including all ChIP-seq profiles from both un-
stimulated macrophages and those stimulated with LPS
for 1 or 4 h, to obtain a single chromatin model ap-
plicable to all conditions. We also added the H3K27ac
and the H3K27me3 marks to this chromatin model,
to help discriminating poised and active/non-active en-
hancers (Supplementary Figure S7A and B). The newly
generated clusters (Figure 5C) revealed the presence of
two groups of H3K4me1/K79me2 enhancers: those with
or without H3K27ac, indicated as active or non-active
H3K79me2 intronic enhancers (states #8 and #7, re-
spectively). Intriguingly, the chromatin state marked by
H3K4me1/K36me3 was identified only with H3K27ac
(state #14), indicating that enhancers marked by K36me3
aremore frequent in an active state. In contrast, H3K27me3
clustered with H3K4me1, but not with H3K79me2 or
H3K36me3. After LPS treatment, chromatin states marked
by H3K4me1/K79me2 or H3K4me1/K36me3 did not
change their distribution (Supplementary Figure S7B), con-
firming that the inflammatory response did not cause ma-
jor changes in genomic distribution of these PTM combi-
nations.
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Figure 5. Characterization of different intronic enhancer subpopulations. (A) Distribution and enrichment of chromatin states in a 10-kb window sur-
rounding TSS. Chromatin states #5 and #6 correspond to regions in which H3K4me1 co-localized with H3K79me2 alone or with H3K4me3, respectively.
Chromatin state #7 represents regions inwhichH3K79me2was co-enrichedwithH3K4me3. The chromatin state #11 represents regions inwhichH3K4me1
andH3K36me3 co-localized. (B) Global distribution of chromatin states #5, #6, #7 and #11. (C) Heatmap representing the chromatin state model at basal
level and after 1 h or 4 h of LPS treatment, including ChIP-seq profiles for H3K27ac and H3K27me3. (D) Distribution of RNA quantification values,
either from total (left and central panel) or nascent (right panel) RNA analysis, associated with different sets of chromatin states. Chromatin states #7,
#8, #14 and #17 represent regions in which H3K4me1 co-localized with K79me2, K27ac/K79me2, K27ac/K36me3 or K27ac, respectively. Chromatin
states #16 and #18 represents instead regions in which H3K4me1 is present alone or in combination with H3K27me3. (E) TF binding motifs enriched for
enhancers marked by H3K4me1/K36me3 and H3K4me1/K79me2.
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We then intersected the newly generated chromatin states
with RNA-seq expression data from resting macrophages
to assess the contribution of these enhancer subpopulations
to the expression of the underlying genes. As expected, tran-
script levels were significantly higher for the genes marked
by eitherH3K79me2 orH3K36me3with respect to all genes
(P < 0.001; two-tailed Z-test) (Figure 5D, left panel), con-
firming them asmarkers of active transcription. As an addi-
tional control, we assessed the level of transcription of genes
containing any of the H3K4me1-positive chromatin states.
As expected, while they displayed significantly higher tran-
scription compared to all genes, their overall expression was
lower than that of genes marked by either H3K79me2 or
H3K36me3 (Figure 5D, left panel). Transcript levels that
associated with genes marked by H3K27me3 were signifi-
cantly lower than the expression level of all genes (Figure
5D, left panel). When we assessed the effect of intronic en-
hancers on transcription, no significant differences (P >
0.2, two-tailed Z-test) were seen between genes contain-
ingH3K4me1/K79me2 orH3K4me1/K36me3 regions and
those with H3K79me2 or H3K36me3 regions. Similarly, no
significant differences were detected when taking into ac-
count the activation state of these intronic enhancers based
on their co-association with H3K27ac (Figure 5D, middle
panel).
Since steady-state transcripts do not necessarily reflect
on-going transcription rates, we profiled nascent RNAs
from 4-thiouridine (4sU) labeled cells (60) and discov-
ered a significantly higher transcriptional activity (P <
0.001; two-tailed Z-test) at genes with H3K79me2- or
H3K36me3-positive active enhancers (Figure 5D, right
panel). This suggests that active intronic enhancers marked
by H3K4me1/K79me2 and H3K4me1/K36me3 might not
simply have a physical connection with their host genes but
rather also play a functional role in their transcriptional reg-
ulation. The transcriptional activity of poised enhancers, in
contrasts, was lower when both total and nascent transcript
levels were compared (Figure 5D, middle and right panels),
in line with previous observations (83).
To assess a potential role of these newly identified classes
of intronic enhancers in controlling inflammatory gene ex-
pression, we interrogated the underlying genomic regions
for enrichment of binding motifs for TFs. Interestingly, we
found specific enrichment of motifs recognized by the NF-
B and IRF proteins (Figure 5E), whose co-occurrence at a
subset of regulatory regions has been previously described
(84,85). In addition, we retrieved motifs for various TFs
known to regulate inflammatory gene expression (e.g. AP-1,
Jun, Fra1 and Fosl2) or to enhance transcriptional activity
(e.g. ETS) (86), and the enrichment of these TFs was more
prominent after LPS stimulation (Figure 5E, Supplemen-
tary Table S5). Hence, our data indicated that these two sub-
populations of enhancers have a role in the transcriptional
activation of the associated genes and contain binding sites
for relevant inflammatory TFs.
Prompted by these findings, we carried out
a gene ontology (GO) enrichment analysis of
the genes hosting the two enhancer subpopula-
tions marked by H3K4me1/K27ac/K79me2 and
H3K4me1/K27ac/K36me3, in both basal and inflamed
states. Several GO terms associated to immunity and
inflammatory response were significantly enriched initially
and were further overrepresented after LPS treatment
(Figure 6A), strengthening the hypothesis that H3K79me2-
and H3K36me3-positive active enhancers increase the
transcriptional activity of genes involved in inflammation-
related pathways. In particular, while more generic GO
categories such as ‘activation of MAPK activity’ and ‘im-
mune response regulating signal transduction’ are common
to both groups, more specific biological functions are
associated with specifically with a mark; thus, activation
and ‘positive regulation of JUN kinase activity’ was uniquely
associated to H3K4me1/K27ac/K79me2 enhancers, while
‘response to lipopolysaccharide’ was over-represented in
the H3K4me1/K27ac/K36me3 enhancers. None of these
GO terms were enriched in control genes marked by
H3K4me1/K27ac only (referred to as class I; (83)), cor-
roborating the assumption that intronic enhancers marked
by the H3K4me1/K79me2 and H3K4me1/K36me3 sig-
natures enforce specific transcriptional programs within
the inflammatory response. In contrast, genes marked
by H3K4me1/K27me3 (referred to as class II; (83)) were
linked to homeostasis (Figure 6A).
Enhancers that convert genes from a poised (class II)
to an active (class I) state play a crucial role during the
transcriptional changes induced in response to stimuli or
that occur during functional and developmental transitions
(83); we therefore focused on the H3K4me1/K27me3 re-
gions that acquired H3K27ac after 4 h of LPS treatment.
We observed that about 2 000 enhancers underwent this
conversion, with ∼5% of them displaying H3K36me2 or
H3K79me2 as an additional mark (Figure 6B). In partic-
ular, GO analysis of the genes with class I H3K36me3 en-
hancers showed an enrichment of terms related to inflam-
matory pathways, including that for I-NF-B. Although
GO analysis of the genes associated to class I H3K79me2
enhancers revealed no specific enrichment of terms or cat-
egories, various interesting genes were included in this
group, such as:MAPK14, a Ser/Thr kinase induced by LPS
with a well-characterized role in inflammation (reviewed
in (87)); SH3PXD2B, encoding a protein required for po-
dosome formation (88); and Trim46 and Tpm1, the pro-
teins of which appear to distinguish functionally different
macrophage subpopulations (89).
TheH3K36me2/K4me1 combination as a novel marker of en-
hancer transcription
The presence of short (<2 kb) non-coding RNAs tran-
scribed bi-directionally from enhancers (eRNAs) has been
recently correlated to enhancer activity and expression of
nearby genes (90,91). The combination of different molecu-
lar features, such as eRNAs and histone modifications (e.g.
H3K27ac) has been previously used to identify active en-
hancers (23,92). A recent study used a logistic regression
model with selected histone PTMs to reveal modification
patterns predictive of eRNA transcription (93). Neverthe-
less, the functional correlation between specific PTM pat-
terns and eRNA transcription has not been systematically
addressed yet.
OurN-ChroP data showed thatH3K36me2 is enriched at
H3K4me1-chromatin regions; as this modification is gen-
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Figure 6. Functional analysis of genes associated with different populations of intronic enhancers. (A) Gene ontology (GO) analysis and enriched pathways
in genes hosting K4me1-, K4me1/K79me2- or K4me1/K36me3-marked active enhancers, at basal state or after LPS stimulus. Significantly enriched GO
terms are indicated both by colour code and the P-value shown within each cell. (B) Conversion of intronic enhancers after LPS induction: schematic
representation of class II enhancers (K4me1/K27me3) that convert to class I enhancers (K4me1/K27ac) after LPS stimulus. GO enrichment of the novel
class I enhancers marked by H3K4me1/K27ac and H3K4me1/K27ac/K36me3 is shown.
erally associated with transcriptional elongation (94–96),
we hypothesized that transcriptional events occurred at re-
gions marked by this pair of histone marks. We tested
this hypothesis using our chromatin state model to iden-
tify extragenic regions marked either by the combina-
tion H3K4me1/K36me2 (#2 and #3; 8757 regions), or
H3K4me1 alone (#16 and #17; 17 941 regions). Both
groups were further divided as ‘active’ or ‘inactive’ based
on the co-association of H3K27ac (Figure 7A and B).
When these regions were interrogated for the presence of ac-
tively ongoing transcription, a significant increase was ob-
served for nascent RNA reads from intergenic enhancers
marked by H3K4me1/K36me2, as compared to reads from
regions marked by H3K4me1 only (P < 0.0001, Mann–
Whitney test) (Figure 7A). After applying a RPKM cutoff
of 0.5, we classified the two sets of transcribed extragenic
enhancers on the basis of annotated genomic features, fo-
cusing on super-enhancers (64) and active enhancers (posi-
tive forH3K4me1 andH3K27ac; (23)) as these elements are
actively transcribed. Indeed, both elements showed a sta-
tistically significant enrichment in H3K36me2-marked en-
hancer regions, as compared to the H3K4me regions (Fig-
ure 7C).
Recent evidence proposes that the RNA pol II actively
contributes to establishing and maintaining characteristic
histone PTM signatures at enhancers, through their tran-
scription (43). To further investigate the emerging cross-talk
between enhancer transcription and H3K36me2, we pro-
filedH3K4me1 andH3K36me2 byChIP-seq after flavopiri-
dol treatment, a drug that inhibits elongation by blocking
Cdk9 (97), both at basal conditions and after LPS stim-
ulation (Supplementary Figure S8A). Transcriptional in-
hibition correlated with the impairment of H3K4me1 de-
position (in line with previous reports; (43)) in regions
marked by H3K4me1, either alone or in combination
with H3K36me2 (Figure 7D, left panel, Supplementary
Figure S8B). Interestingly, we observed that H3K36me2
decreased at intergenic regions, both in basal and LPS-
induced states, when transcription elongation was inhib-
ited (Figure 7D, right panel). Moreover, the reduced depo-
sition of H3K4me1 was more prominent in extragenic en-
hancers when it co-localized with H3K36me2 (Figure 7D,
left panel), supporting the idea that K36me2 is an addi-
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tionalmark of transcribed enhancers and that its deposition
at these regulatory regions requires transcription.
As a complementary strategy, we also assessed the im-
pact of H3K36me2 deposition on enhancer transcription
during inflammation. In mammalians, SETD2 is known to
tri-methylate H3K36, while various enzymes display mono-
and di-methylase activity at this residue, such as NSD1,
NSD2 and NSD3, which constitute the NSD family of
K-methyl-transferases and were shown to mono- and di-
methylate K36 in vivo (98–100). Based on this enzymatic
activity and in order to tackle H3K36me2 level, we si-
lenced NSD1 and NSD2, individually or in combination,
in RAW 264.7 cells, unstimulated or stimulated with LPS
for 4 h in two biological replicates. Enzymes knock-down
was achieved with lentivirus-mediated short hairpin RNA
interference (shRNA) (Figure 7E and F). Bulk H3K36me2
reduction was assessed by western blot (Figure 7G) and fur-
ther confirmed by H3K36me2 ChIP, followed by qPCR, at
a pool of extragenic regions previously identified as marked
by H3K4me1/K36me2 (Figure 7H). Intriguingly, we ob-
served that after LPS treatment nascent transcripts were re-
duced in samples depleted for NSD1 and NSD2 at about
40% of the regions assessed (Figure 7I). This reduction
seems to be more pronounced after NSD1 depletion and
in the combined knock-down than in NDS2-depleted cells,
suggesting a more prominent role of NSD1 in the deposi-
tion of K36me2 at these transcribed enhancers.
Overall, our results indicate that -at least in a subset of
enhancers- H3K36me2 deposition is interlinked with their
transcription, possibly serving as docking site for transcrip-
tional co-regulators.
DISCUSSION
Here, we performed a widespread characterization of
histone PTMs associated to cis-regulatory regions in
macrophages, focusing on enhancers that are poorly char-
acterized from amolecular point of view despite their estab-
lished role in sustaining and coordinating cell- and stimulus-
specific transcriptional programs. As bait for our N-ChroP
proteomics approach, we chose three histone marks with
distinct genomic locations and functions: H3K4me1 and
H3K4me3 mark enhancers and promoters, respectively
(20), and H3K9me3 marks heterochromatin (used as a neg-
ative control). The enrichment of specific regulatory regions
by multiple histone modifications has been recently used
for the proteomics identification of interactors (101), but
a systematic MS-characterization of histone modifications
at these genomic elements has never previously been ad-
dressed.
We profiled 42 differentiallymodified peptides forH3 and
H4, with the unique possibility of inferring functional PTM
associations, not only within the same histone molecule,
but also among different histones belonging to the same
nucleosome, thanks to the enrichment of intact nucleo-
somes. Analyzing the modification patterns more specifi-
cally associated with H3K4me1 and H3K4me3 chromatin,
we observed that H3K79me2 was enriched at both cis-
regulatory regions, while H3K36me2 and H3K36me3 ac-
cumulated only at H3K4me1-enhancers. Because of their
typical association with transcribed gene bodies, the pres-
ence of H3K36me2/me3 and H3K79me2 at enhancers was
unexpected and prompted us to investigate it further. ChIP-
seq analysis confirmed the co-association of H3K4me1
with these marks, and hinted at the existence of different
enhancer subpopulations marked by distinct PTM signa-
tures. The subsequent intersection of the resulting chro-
matin states with transcriptomics data permitted us to dis-
tinguish different enhancer classes that have distinct fea-
tures and transcriptional activity. In particular, we iden-
tified two groups of intronic enhancers marked by either
H3K4me1/K79me2 or H3K4me1/K36me3, which associ-
atedwith highly transcribed genes involved in different tran-
scriptional programs of macrophage inflammation.
We propose that these intergenic enhancers modulate
the expression of the nearby genes. This still needs to be
functionally corroborated with further experiments; for in-
stance, DNA editing could be used to selectively delete pu-
tative intronic enhancers and then assess the transcriptional
response upon inflammation; alternatively, chromatin con-
formation capture approaches to determine the three-
dimensional organization analysis of the genomes around
these regulatory regions may reveal interactions between
putative enhancer sub-groups and promoters, thereby help-
ing to identify regulated genes.
By integrating nascent transcript analysis with
ChIP-seq and proteomics data, we discovered that the
H3K4me1/K36me2 combination tags actively transcribed
enhancers and, in particular, super-enhancers, and that
H3K36me2 deposition at these regions is linked to their
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
model. Within these classes, active or non-active enhancers were also divided based on the presence or absence of H3K27ac, and the distribution of
transcript levels associated with the two groups is shown. (B) Examples of representative genomic regions displaying H3K4me1, H3K36me2, H3K27ac
and nascent RNA enrichment. (C) Distribution of transcribed extragenic enhancers belonging to the K4me1 and K4me1/K36me2 groups, as compared to
annotated genomic features; the enrichment of active and super-enhancers in the H3K4me1/K36me2 group is highlighted. (D) Distribution of H3K4me1
(left) and H3K36me2 (right) normalized read counts in H3K4me1/K36me2-marked enhancers in cells untreated or LPS-stimulated, with or without
flavopiridol (FP) pretreatment. (E) mRNA levels of NSD1 and NSD2 measured by RT-qPCR analyses in RAW 264.7 cells expressing the scrambled
(shScramble) and NSD1- and NSD2-specific shRNAs (shNSD1 and shNSD2). Gene expression is normalized to TBP mRNA level. Values are expressed
as mean ± s.e. (standard error) of two biological replicates (n = 2). (F) NSD1 protein level in cells expressing scrambled (shScramble) and NSD1-specific
shRNA (upper panel). Protein LFQ ratio distribution from label-free quantitative (LFQ)MS-analysis of whole extracts from cells expressingNSD2-specific
shRNAs (shNSD2) versus shScramble cells. NSD2 LFQ ratio value is indicated with the green dot and equals log2 = –1.4, confirming its down-regulation.
(G) Western blot analysis of H3K36me2 from protein extracts from cells expressing scrambled (shScramble) and NSD1- and NSD2-specific shRNAs
(shNSD1 and shNSD2). Vinculin and Ponceau staining are used as loading control. (H) qPCR of extragenic regions marked by H3K4me1/K36me2 after
H3K36me2 ChIP in cells expressing scrambled (shScramble) or NSD1- and NSD2-specific shRNAs (shNSD1 and shNSD2), at 4 h after LPS treatment.
Data are expressed as percent of the input. (I) Quantitative RT-qPCR using 4sU-labeled RNAs on extragenic regions marked by H3K4me1/K36me2 in
cells expressing scrambled (shScramble) and NSD1- and NSD2-specific shRNAs (shNSD1 and shNSD2), at 4 h after LPS treatment. Values are expressed
as mean ± s.e. (standard error) of two biological replicates (n = 2).
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active transcription. Super-enhancers are defined as
clusters of transcriptional enhancers densely bound by
TFs and other co-regulators, which play a critical role in
defining cell identity by regulating cell type–specific genes
located in close proximity (64,102). Although H3K27ac
accumulates at these elements and was initially considered
as a hallmark of super-enhancer, this mark alone is in fact
insufficient to identify these elements comprehensively and
unambiguously. Given that the presence of eRNAs marks
enhancer activation in macrophages (103), our finding sug-
gests that the newly identified H3K4me1/K27ac/K36me2
signature may be used for de novo identification of ac-
tive super-enhancers. Interestingly, we also found that
H3K36me2 deposition seems to be linked to the transcrip-
tion of a subset of extragenic regions marked by the dual
K4me1/K36me2 signature, suggesting a possible role of
this mark in enforcing active enhancer transcription.
Quite unexpectedly, H3K27 acetylation showed a de-
creasing trend in ChroP over the time course after LPS. This
result may be explained by the fact that macrophages re-
act to inflammation with a composite response comprising
both activation of ‘poised’ enhancers that regulate inflam-
matory genes and silencing of active enhancers of house-
keeping or survival genes; hence, downregulation of K27ac
may result from an overall reduction in the number of active
enhancers within the pool of the precipitated H3K4me1-
nucleosomes (54). This reveals a possible limitation of the
current N-ChroP setup when applied to the dynamic pro-
filing of low abundance PTMs: because N-ChroP enriches
the complete pool for all possible H3K4me1-positive en-
hancers, the MS-based readout ‘averages’ among histone
modification patterns of the bulk of enhancers, which may
hide the dynamic behavior of rare modifications that mark
only a small fraction of enhancers. Re-ChIP experiments, in
combination with MS, could offer a solution to overcome
this constraint, although MS sensitivity remains a major
challenge.
In sum, our results with N-ChroP have confirmed its
strong potential for discovering novel combinatorial his-
tone PTMs thatmark functionally distinct genomic regions.
While the MS findings still need to be complemented with
next-generation sequencing data (e.g. ChIP-seq and RNA-
seq) to define the genome-wide distribution of these combi-
natorial marks and to assess their functional outcome, in-
tegrating proteomics with ChIP-seq data can improve en-
hancer identification and provide hints about unexpected
cross-talk between different chromatin determinants (such
as between eRNAs and histone modifiers, as shown here).
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